Skip to main content
SpringerLink
Log in

Hypertension in Kidney Disease

  • Chapter
Hypertension in Kidney Disease

Part of the book series: Developments in Nephrology ((DINE,volume 14))

Abstract

Vascular tone and body fluid volume, the two dominant factors that determine arterial blood pressure, are controlled by the kidneys. Because of this, the kidneys play a central role in the regulation of normal arterial pressure and the development of hypertensive disorders [1–4]. Hypertension in kidney disease may be initiated by either increased cardiac output, increased total peripheral vascular resistance or both, but it is usually sustained by the latter [5–9]. The mechanism of the elevated total peripheral vascular resistance is multifactorial and complex. Although one mechanism, such as hyperreninemia or excessive sodium-fluid volume may be operational to initiate or maintain hypertension, it is more often that multiple mechanisms, in varying degrees at different stages, contribute to sustain hypertension [1, 3, 10–15] (Table 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Laragh JH, Sealy JE, Niarchos AP, Pickering PG: The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension. Fed Proc 41:2415–2423, 1982.

    PubMed  CAS  Google Scholar 

  2. Guyton AC, Hall JE, Lohmeier M et al.: The concept of whole body autoregulation and the dominant role of the kidneys for long-term blood pressure regulation. In: Laragh JH, Buhler FR, Seldin DW (eds), Frontiers in Hypertension Research. Springer-Verlag, New York-Heidelberg-Berlin, 125–134, 1982.

    Google Scholar 

  3. Ferris TF: The kidney and hypertension. Arch Int Med 142:1889–1895, 1982.

    Article  CAS  Google Scholar 

  4. Guyton AC, Colemen TG, Coleman TG, Cowley AW Jr et al.: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594, 1972.

    Article  PubMed  CAS  Google Scholar 

  5. Cangiano JL, Ramirez-Muxo O, Ramirez-Gonzalez R, Trevino A et al.: Normal renin uremic hypertension. Study of cardiac hemodynamics, plasma volume, extra-cellular fluid volume and the renin-angiotensin system. Arch Int Med 136:17–23, 1976.

    Article  CAS  Google Scholar 

  6. Coleman TG, Bower JD, Langford HG et al.: Regulation of arterial pressure in the anephric state. Circulation 52:509–514, 1970.

    Google Scholar 

  7. Frohlich ED, Tarazi RC, Dustan HP: Re-examination of the hemodynamics of hypertension. Am J Med 257:9–23, 1969.

    Article  CAS  Google Scholar 

  8. Kim KE, Onesti G, Fernandes M et al.: Hemodynamics of hypertension. In: Onesti G, Fernandes M, Kim KE (eds), Regulation of Blood Pressure by the Central Nervous System. Grune and Stratton, New York, 337–353, 1976.

    Google Scholar 

  9. Kim KE, Onesti G, Swartz C: Hemodynamics of hypertension in uremia. Kid Int 7(Suppl 2):155–162, 1975.

    Google Scholar 

  10. Weidmann P, Beretta-Piccoli C, Steffen F et al.: Hypertension in terminal renal failure. Kid Int 9:294–301, 1976.

    Article  CAS  Google Scholar 

  11. Brunner N: Angiotensin II vascular receptors: Their avidity in relationship to sodium balance, the autonomic nervous system and hypertension. J Clin Invest 51:58–64, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Frohlich ED: Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed Proc 41:2400–2408, 1982.

    PubMed  CAS  Google Scholar 

  13. Warren DJ, Ferris TF: Renin secretion in renal hypertension. Lancet 2:159–162, 1970.

    Article  Google Scholar 

  14. Brown JJ, Davies DL, Morton JJ et al.: Mechanism of renal hypertension. Lancet 1:1219–1221, 1976.

    Article  PubMed  CAS  Google Scholar 

  15. Lipson LG: Special problems in treatment of hypertension in the patients with diabetes mellitus. Arch Int Med 144:1829–1831, 1984.

    Article  CAS  Google Scholar 

  16. Tuttle E: Hypertension complicating renal disease. In: Bloonfield NJ. Hypertension Update Mechanisms, Epidemiology, Evaluation, Management. Health Learning System, 76#x2013;84, 1980.

    Google Scholar 

  17. Baldwin DS: Mechanisms of progression in glomerulonephritis. Clin Exper Dialysis Apheresis 5:1–10, 1981.

    CAS  Google Scholar 

  18. Baldwin DS: Chronic glomerulonephritis: Non-immunologic mechanisms of progressive glomerular damage. Kid Int 31:109–120, 1982.

    Article  Google Scholar 

  19. Cheigh JS, Stenzel KH, Rubin AL et al.: Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 75:602–606, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Oksa H, Pasternack A, Luomala M et al.: Progression of chronic renal failure. Nephron 35:31–34, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Wilson C, Byron FB: The vicious cycle in chronic Bright’s disease. Experimental evidence from the hypertensive rat. Quart J Med 10:65–93, 1941.

    Google Scholar 

  22. Berglund G, Andersson O, Wilhelmsen L: Prevalance of primary and secondary hypertension: Studies in a random population sample. Br Med J 2:554–556, 1976.

    Article  PubMed  CAS  Google Scholar 

  23. Rudnick KV, Sackett DL, Hirst S et al.: Hypertension in a family practice. CMAJ 117:492–497, 1977.

    CAS  Google Scholar 

  24. Danielson M, Damnstroem B: The prevalence of secondary and curable hypertension. Acta Med Scand 209:451–455, 1981.

    Article  PubMed  CAS  Google Scholar 

  25. Gifford RW Jr: Evaluation of the hypertensive patient with emphasis on detecting curable causes. Milbank Mem Fund Q 47:170–186, 1969.

    Article  Google Scholar 

  26. Lins L-E, Eliasson K: Erfarenheter Fran Karolinska sjukhusets hypertonimottagning. I: Hypertonimoten pa svenska lakaresallskapet. Stockholm, 1978.

    Google Scholar 

  27. Ahlmen J: Incidence of chronic renal insufficiency. A study of the incidence and pattern of renal insufficiency in adults during 1966–1971 in Gothenburg. Acta Med Scand 582:3–50, 1975.

    Google Scholar 

  28. Calabrese G, Vagelli G, Cristopano C et al.: Behavior of arterial pressure in different stages of polycystic kidney disease. Nephron 32:207–208, 1982.

    Article  PubMed  CAS  Google Scholar 

  29. Rao TK, Gupta SK, Butt K et al.: Relationship of renal transplantation to hypertension in end-stage renal failure. Arch Int Med 138:1236–1241, 1978.

    Article  Google Scholar 

  30. Cheigh JS, Wang J, Fine P et al.: Hypertension and decreased graft survival in long-term kidney transplant recipients. Transplant Proc 17:174–175, 1985.

    Google Scholar 

  31. Simon HB, Thompson GJ: Congenital renal polycystic disease. A clinical and therapeutic study of three hundred sixty-six cases. JAMA 159:657–622, 1955.

    CAS  Google Scholar 

  32. Johnson JG, Hunt JC: Hypertension secondary to renal parenchymal disease. In: Amery A, Fagard R, Lijnen P, Staessen J (eds), Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Martinus Nijhoff Publishers, The Hague/Boston/London, 508–525, 1982.

    Google Scholar 

  33. Riaj L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kid Int 26:137–143, 1984.

    Article  Google Scholar 

  34. Dworkin LD, Hostetter TH, Rennke HG et al.: Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 73:1448–1461, 1984.

    Article  PubMed  CAS  Google Scholar 

  35. Motoki K, Kusyarna Y, Ueno Y et al.: Chronic nephrotoxic nephritis in spontaneously hypertensive rats. Jpn Heart J 19:662–664, 1978.

    Article  PubMed  CAS  Google Scholar 

  36. Tikkanen I, Fyhrquist F, Miettinen A et al.: Autologous immune complex nephritis and DOCA NaCl load: A new model of hypertension. Acta Path Microbiol Scand (Section A) 88:241–250, 1980.

    CAS  Google Scholar 

  37. Neugarten J, Feiner HD, Schacht RG et al.: Aggravation of experimental glomerulonephritis by superimposed clip hypertension. Kid Int 22:257–263, 1982.

    Article  CAS  Google Scholar 

  38. Wilson C, Pickering GW: Acute arterial lesions in rabbits with experimental renal hypertension. Clin Sci 3:343–355, 1938.

    Google Scholar 

  39. Sommers SS: Pathology of the kidney and adrenal gland in relationship to hypertension. In: Moyer JH (ed.), Hypertension, First Hahnemann Symposium on Hypertensive Disease. W.B. Saunders, Co., Philadelphia, 8, 1959.

    Google Scholar 

  40. McManus JFA, Lupton CH Jr: Ischemia obsolescence of renal glomeruli. The natural history of the lesions and their relation to hypertension. Lab Invest 9:413–434, 1960.

    Google Scholar 

  41. Muirhead EE, Booth E, Montgomery P: Derivation of certain forms of ‘fibrinoid’ from smooth muscle. Arch Pathol 63:213–228, 1957.

    CAS  Google Scholar 

  42. Hill GS, Heptinstall RH: Steroid-induced hypertension in the rat. A microangiographic and histologic study on the pathogenesis of hypertensive vascular and glomerular lesions. Am J Pathol 52:1–39, 1968.

    PubMed  Google Scholar 

  43. Still WJS, Dennison SM: The pathogenesis of the glomerular changes in steroid-induced hypertension in the rat. Lab Invest 20:249–260, 1969.

    PubMed  CAS  Google Scholar 

  44. Azar S, Johnson MA, Hertel B et al.: Single-nephron pressures, flows and resistances in hypertensive kidneys with nephrosclerosis. Kid Int 12:28–40, 1977.

    Article  CAS  Google Scholar 

  45. Azar S, Johnson MA, Iwai J et al.: Single Nepron dynamics in ‘post-salt’ rats with chronic hypertension. J Lab Clin Med 91:156–166, 1978.

    PubMed  CAS  Google Scholar 

  46. Azar S, Johnson MA, Scheinman J et al.: Regulation of glomerular capillary pressure and filtration rate in young Kyoto hypertensive rats. Clin Sci 56:203–209, 1979.

    PubMed  CAS  Google Scholar 

  47. Dworkin LD, Feiner HD, Randazzo J: Evidence for hemodynamically mediated glomerular injury despite antihypertensive therapy in rats with desoxycorticosterone-salt hypertension. Am Soc Nephrol, Washington DC, 91A (Abstract), December 9–12, 1984.

    Google Scholar 

  48. Hostetter TH, Rennke HG, Brenner BM: Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kid Dis 1:310–314, 1982.

    PubMed  CAS  Google Scholar 

  49. Brenner BM, Meyer TW, Hostetter T: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in the aging, renal ablation and intrinsic renal disease. N Engl J Med 37:652–655, 1982.

    Google Scholar 

  50. Urakabe S, Shirai D, Orita Y et al.: Prognosis of chronic glomerulonephritis with special reference to hypertension and renal function. Jap Circ J 39:815–821, 1975.

    Article  PubMed  CAS  Google Scholar 

  51. Urakabe S, Orita Y, Shirai D et al.: Prognosis of chronic glomerulonephritis in adult patients estimated on the basis of the Markow process. Clin Nephrol 3:48–53, 1975.

    PubMed  CAS  Google Scholar 

  52. Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36:383–388, 1976.

    Article  PubMed  CAS  Google Scholar 

  53. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93, 1984.

    Article  PubMed  CAS  Google Scholar 

  54. Bengtsson U: Long term pattern in chronic pyelonephritis. Contr Nephrol 16:31–36, 1979.

    CAS  Google Scholar 

  55. Donodia JV Jr, Slack TK, Holley KE et al.: Idiopathic membranoproliferative (mesangio-capillary) glomerulonephritis. A clinicopathologic study. Mayo Clin Proc 54:141–150, 1979.

    Google Scholar 

  56. Budman A, Steinberg AD: Hypertension and renal disease in systemic lupus erythematosus. Arch Int Med 136:1003–1007, 1976.

    Article  CAS  Google Scholar 

  57. Appel GB, Silva FG, Pirani DL et al.: Renal involvement in systemic lupus erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Med 57:371–410, 1978.

    CAS  Google Scholar 

  58. Cameron JS, Turner DR, Ogg CS et al.: Systemic lupus with nephritis: A long-term study. Quart J Med 58:1–24, 1979.

    Google Scholar 

  59. Ramzy MH, Cameron JS, Turner DR et al.: The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 16:13–19, 1981.

    PubMed  CAS  Google Scholar 

  60. Veterans Administration Cooperative study Group on Antihypertensive Agents. Effects of treatment on morbidity in Hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202:116–122, 1967.

    Article  Google Scholar 

  61. Breckenridge A, Dollery CT, Parry EHO: Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Quart J Med 39:411–429, 1970.

    PubMed  CAS  Google Scholar 

  62. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mg/Hg. JAMA 213:1143–1152, 1970.

    Article  Google Scholar 

  63. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562–2571, 1979.

    Article  Google Scholar 

  64. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 247:633–638, 1982.

    Article  Google Scholar 

  65. Folsom AR, Luepker RV, Gillum RF et al.: Improvement in hypertension detection and control from 1973–1974 to 1980–1981. The Minnesota Heart Survey Experience. JAMA 250:916–921, 1983.

    Article  PubMed  CAS  Google Scholar 

  66. Moyer JH, Heider C, Pevey K et al.: The effects of treatment of the vascular deterioration associated with hypertension with particular emphasis on renal function. Am J Med (Feb):177–192, 1958.

    Google Scholar 

  67. Woods JW, Blythe WB: Management of malignant hypertension complicated by renal insufficiency. N Engl J Med 277:57–61, 1967.

    Article  PubMed  CAS  Google Scholar 

  68. Mroczek WJ, Davidov M, Gavrilovich L et al.: The value of aggressive therapy in the hypertensive patients with azotemia. Circulation 15:893–904, 1969.

    Google Scholar 

  69. Woods JW, Blythe WB, Huffines WD: Management of malignant hypertension complicated by renal insufficiency. A follow-up study. N Engl J Med 291:10–14, 1974.

    Article  PubMed  CAS  Google Scholar 

  70. Pohl JEF, Thurston H, Swales JD: Hypertension with renal impairment: Influence of intensive therapy. Quart J Med 18:569–581, 1974.

    Google Scholar 

  71. Davidov M, Mroczek W, Gavrilovich L et al.: Long-term follow-up of aggressive medical therapy of accelerated hypertension with azotemia. Angiol 26:396–407, 1975.

    Article  Google Scholar 

  72. Luft Fc, Bloch R, Szwed JJ et al.: Minoxidil treatment of malignant hypertension. Recovery of renal function JAMA 240:1985–1987, 1978.

    Article  PubMed  CAS  Google Scholar 

  73. Perera GA: Hypertensive vascular disease; Description and natural history. J Chron Dis 1:33–42, 1955.

    Article  PubMed  CAS  Google Scholar 

  74. Kincaid-Smith P, McMichael J, Murphy EA: Clinical course and pathology of hypertension with papilledema (malignant hypertension). Q J Med 26:117–163, 1958.

    Google Scholar 

  75. Mroczek WJ: Malignant hypertension: Kidneys too good to be extirpated. Ann Int Med 80:754–757, 1974.

    PubMed  CAS  Google Scholar 

  76. Mogensen CE: Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685–688, 1982.

    Article  CAS  Google Scholar 

  77. Parving HH, Andersen AR, Smidt UM et al.: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175–1179, 1983.

    Article  PubMed  CAS  Google Scholar 

  78. Wollenweber J, Sheps Sg, Davis GD: Clinical course of atherosclerotic renovascular disease. Am J Cardiol 21:60–71, 1968.

    Article  PubMed  CAS  Google Scholar 

  79. Dean RH, Kieffer RW, Smith BM et al.: Renovascular hypertension: Anatomic and renal function changes during drug therapy. Arch Surg 116:1408–1415, 1981.

    PubMed  CAS  Google Scholar 

  80. Thomas JM, Pfaff WW: Acute anuria secondary to renal artery stenosis. Ann Surg 183:293–295, 1976.

    Article  PubMed  CAS  Google Scholar 

  81. Besareb A, Brown RS, Rubin NT et al.: Reversible renal failure following bilateral renal artery occlusive disease, Clinical feature, pathology and the role of surgical revascularization. JAMA 235:2838–2841, 1976.

    Article  Google Scholar 

  82. Schreiber MJ, Novick AC, Pohl MA: The natural history of atherosclerotic and fibrous renal artery disease. Kid Int 19(Abstract):175, 1981.

    Google Scholar 

  83. Textor SC, Novick AC, Tarazi RC et al.: Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Int Med 102:308–314, 1985.

    PubMed  CAS  Google Scholar 

  84. Ying CY, Tifft CP, Garras H et al.: Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 311:1070–1075, 1984.

    Article  PubMed  CAS  Google Scholar 

  85. Berguer R, Hwang NHC: Critical arterial stenosis: a theoretical and experimental solution. Ann Surg 180:39–50, 1974.

    Article  PubMed  CAS  Google Scholar 

  86. Novick AC, Straffon RA, Stewart BH et al.: Diminished operative morbidity and mortality in renal revascularization. Jama 246:749–753, 1981.

    Article  PubMed  CAS  Google Scholar 

  87. Madias NE, Kwon OJ, Millan VG: Percutaneous transluminal renal angioplasty. A potentially effective treatment for preservation of renal function. Arch Int Med 142:693–697, 1982.

    Article  CAS  Google Scholar 

  88. Sos TA, Pickering TG, Sniderman K et al.: Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 309:274–279, 1983.

    Article  PubMed  CAS  Google Scholar 

  89. Sniderman KW, Sos TA, Sprayregen S et al.: Percutaneous transluminal angioplasty in renal transplant arterial stenosis for relief of hypertension. Diagn Radiol 135/1:23–26, 1980.

    CAS  Google Scholar 

  90. Libertine JA, Zinman L, Breslin DJ et al.: Renal artery revascularization. Restoration of renal function. JAMA 244:1340–1342, 1980.

    Article  Google Scholar 

  91. Osborne RW Jr, Goldstone J, Hillman BJ et al.: Digital video substraction angiography: Screening technique for renovascular hypertension. Surgery 90:932–939, 1981.

    PubMed  Google Scholar 

  92. Council on scientific affairs, American Medical Association: Percutaneous transluminal angioplasty. JAMA 251:764–768, 1984.

    Article  Google Scholar 

  93. Medsger TA, Masi A, Rodnan GP et al.: Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Int Med 75:369–376, 1971.

    PubMed  Google Scholar 

  94. Cannon PS, Hassar M, Case DB et al.: The relationship of Hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Med 53:1–46, 1974.

    CAS  Google Scholar 

  95. Cheigh JS, Kim SJ: Scleroderma kidney disease: a therapeutic approach with nephrectomy and hemodialysis. J Dialysis 1:329–356, 1977.

    Google Scholar 

  96. Richardson JA: Hemodialysis and kidney transplantation for renal failure from scleroderma. Arthritis Rhem 16:265–271, 1973.

    Article  CAS  Google Scholar 

  97. Lam M, Ricanti E, Khan MA et al.: Reversal of severe renal failure in systemic sclerosis. Ann Int Med 89:642–643, 1978.

    PubMed  CAS  Google Scholar 

  98. Mitnick PD, Feig PU: Control of hypertension and reversal of renal failure in scleroderma. N Engl J Med 299:871–872, 1978.

    Article  PubMed  CAS  Google Scholar 

  99. Wasner C, Cooke CR, Fries JF: Successful medical treatment of sclerderma renal crisis. N Engl J Med 299:873–875, 1978.

    Article  PubMed  CAS  Google Scholar 

  100. Markenson JA, Sherman RL: Renal involvement in progressive systemic sclerosis: Prolonged survival with aggressive antihypertensive management. Arthritis Rheum 22:1132–1134, 1979.

    Article  PubMed  CAS  Google Scholar 

  101. Lopez-Ovejero JA, Saal SD, D’Angelo W et al.: Reversal of vascular renal crisis of scleroderma by oral angiotensin converting enzyme blockage. N Engl J Med 300:1471–1472, 1979.

    Article  Google Scholar 

  102. Ponticelli C, Ambroso G, Graziani G et al.: Reversible acute renal failure in diffuse scleroderma. Clin Nephrol 13:293–295, 1980.

    PubMed  CAS  Google Scholar 

  103. Cameron JS: The natural history of glomerulonephritis. In: Kincaid-Smith P, d’Apice AJF, Atkins RC (eds), Progress in Glomerulonephritis. A Wiley Medical Publication, New York, Chichester, Brisbane, Toronto, 1979.

    Google Scholar 

  104. Neugarten J, Kaminetsky B, Feine H et al.: Nephrotoxic serum nephritis with hypertension: Amelioration by antihypertensive therapy. Am Soc Nephrol, Washington DC, 150A (Abstract), December 9–12, 1984.

    Google Scholar 

  105. Masson GMC, McCormack LJ, Dustan HP et al.: Hypertensive vascular disease as a consequence of increased arterial pressure. Quantitative study in rats with hydralazine-treated renal hypertension. Am J Pathol 34:817–833, 1958.

    PubMed  CAS  Google Scholar 

  106. Feld LG, Van Leiw JB, Brentjens JR et al.: Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kid Int 20:606–614, 1981.

    Article  CAS  Google Scholar 

  107. McQueen EG, Hodge, JV: Modification of secondary lesions in renal hypertensive rats by control of the blood pressure with reserpine. Quart J Med 30:213–230, 1961.

    PubMed  CAS  Google Scholar 

  108. Raij L, Azar S, Keane WF: Role of salt induced hypertension and dietary protein in the progression of glomerular damage in glomerulonephritis. Am Soc Nephrol, Washington DC 151A (Abstract), December 9–12, 1984.

    Google Scholar 

  109. Meyer TW, Anderson S, Rennke HG et al.: Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Am J Med 79(Suppl 3C):31–36, 1985.

    Article  PubMed  CAS  Google Scholar 

  110. Wallin JD: Antihypertensives and their impact on renal function. Am J Med (Suppl. October 17):103–108, 1983.

    Google Scholar 

Download references

Authors
  1. Jhoong Shik Cheigh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt H. Stenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albert L. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cornell University Medical Center Rogosin Kidney Center, The New York Hospital, New York, New York, USA

    Jhoong S. Cheigh , Kurt H. Stenzel  & Albert L. Rubin ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Cheigh, J.S., Stenzel, K.H., Rubin, A.L. (1986). Hypertension in Kidney Disease. In: Cheigh, J.S., Stenzel, K.H., Rubin, A.L. (eds) Hypertension in Kidney Disease. Developments in Nephrology, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4271-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4271-4_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8397-3

  • Online ISBN: 978-94-009-4271-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation